Tuesday, 08/10/2024
Bắc giang 26 °C / 23 - 27 °C
Hotline: +84.0204.3 856 624

Society
Hot news:
Society
icon
0.5 1.0 1.5
Shares:
icon-zalo

Nano Covax Covid-19 vaccine candidate to be assessed by Indian institute

Updated: 11:51, 24/09/2021
The Translational Health Science & Technology Institute (THSTI) will evaluate immunogenicity of the Made-in-Vietnam Nano Covax Covid-19 vaccine candidate developed by Nanogen Pharmaceutical Biotechnology of Vietnam.

A memorandum of understanding to this effect was signed at a ceremony held in Faridabad city of India’s Haryana state on September 23.

Under the agreement, Nanogen will send cell samples of volunteers participating in the third trial phase of Nano Covax to the THSTI for assessment.

{keywords}

Vaccine Nano Covax.

Vietnamese Ambassador to India Pham Sanh Chau affirmed that the collaboration with the THSTI holds significant meaning for Nanogen in the research and development of the vaccine candidate.

The Indian institute’s objective evaluation will help confirm the quality of Nano Covax and serve as a foundation for Nanogen to produce the homegrown Covid-19 vaccine for domestic use as well as for export.

THSTI is an institute of the Department of Biotechnology at the Ministry of Science and Technology of India. It has taken part in various vaccine development, assessment and trials in the country.

Nanogen is working with relevant Vietnamese agencies to step up trials of the vaccine candidate so that it will soon receive approval for emergency use in Vietnam.

Over 1,000 second shots of Nano Covax vaccine administered to volunteers in third-phase trials
More than 1,000 volunteers received their second shots of homegrown Nano Covax vaccine in its third phase of human trials, as announced by the Defence Ministry’s Military Medical University on July 19.
13,000 shots of Nano Covax vaccine administered to volunteers in third trial phase
As many as 13,000 shots of homegrown Nano Covax vaccine were administered to volunteers aged 18-75 in the third trial phase as of July 14.
Over 900 more volunteers get Nano Covax shots in third phase of clinical trial
More than 900 out of 12,000 volunteers participating in the second stage of the third phase of the homegrown Covid-19 vaccine Nano Covax’s clinical trial received their first shots on July 2.
Phase 3 human trials of homegrown Nano Covax vaccine to begin on June 8
More than 6,000 volunteers have registered for the third phase of human trials of homegrown Nano Covax vaccine, which is scheduled to begin on June 8, according to the Military Medical University (MMU) under the Defence Ministry.
“Made-in-Vietnam” Nano Covax is expected to be licensed in August
Nano Covax, a Made-in-Vietnam vaccine against Covid-19, is expected to complete the registration dossier and meet requirements for urgent licensing in mid-August.

Source: NDO/VNA

Shares:
icon-zalo
nano-covax-covid-19-vaccine-candidate-to-be-assessed-by-indian-institute.bbg

Reader's comments (0)

Your comment...